WHO Issues Concern Over Severe Scarcity of Obesity Medications

Less than one in 10 people that would benefit from weight-loss injections like Wegovy can access them, states the World Health Organization as it publishes its initial recommendations on the drugs.

Given in excess of 1,000,000,000 individuals worldwide now classified as obese, it is calling for broader and more equitable availability to GLP-1 medication.

According to projections, in excess of 2,000,000,000 are projected to be obese by 2030 unless action is taken.

"The latest guidelines affirms that excess weight is a long-term condition that can be addressed with comprehensive and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.

Substantial prices, constrained manufacturing, and logistical bottlenecks are major barriers to widespread access to the treatments that can assist patients in reducing substantial body mass, notes the organization.

Skinny Jab Supply Crisis

Even in the current most favorable case, the supply of GLP-1 therapies might only reach about 100 million people – under 10% of those who need them, as stated by the WHO.

The advice urges governments and firms to widen access, by approaches including voluntary licensing.

Exclusive production rights on the active ingredient – the core component of Novo Nordisk's Wegovy – is set to lapse in a number of countries in 2026.

How Weight-Loss Drugs Function

GLP-1 drugs replicate a biological compound to delay gastric emptying, curb appetite and boost feelings of fullness so users consume fewer calories.

People typically start to lose weight after several weeks of beginning the weekly injections.

Evidence suggests users may see weight return after a year of halting the medication, when their typical food cravings come back.

To be carrying excess weight elevates your chance for experiencing medical conditions, such as type 2 diabetes, cardiovascular issues, stroke, and certain cancers.

Excess weight affects people in all nations and was linked to over three and a half million deaths worldwide in 2024, per the health agency.